Nine Monthly Results Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Net Sales
6,397.11
5,618.80
4,917.97
4,427.74
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
6,397.11
5,618.80
4,917.97
4,427.74
Raw Material Cost
1,852.06
1,576.75
1,195.70
1,328.46
Purchase of Finished goods
870.60
739.71
749.75
423.82
(Increase) / Decrease In Stocks
-445.99
-376.85
-81.87
-141.07
Employee Cost
1,695.46
1,535.35
1,422.82
1,185.92
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
1,541.14
1,477.51
1,354.60
1,078.91
Total Expenditure (Excl Depreciation)
5,513.27
4,952.47
4,641.00
3,876.04
Operating Profit (PBDIT) excl Other Income
883.84
666.33
276.97
551.70
Other Income
92.78
149.01
200.61
197.66
Operating Profit (PBDIT)
976.62
815.34
477.58
749.36
Interest
317.91
334.27
239.93
141.19
Exceptional Items
0.00
-32.27
-6.96
-15.08
Gross Profit (PBDT)
658.71
448.80
230.69
593.09
Depreciation
573.58
544.44
492.28
421.02
Profit Before Tax
102.18
-81.69
-246.02
181.25
Tax
204.21
35.26
21.53
40.14
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
-119.08
-130.90
-283.12
131.93
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-119.08
-130.90
-283.12
131.93
Share in Profit of Associates
56.71
47.45
46.55
39.97
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
-62.37
-83.45
-236.57
171.90
Equity Capital
1,323.58
1,322.95
1,193.32
1,185.91
Face Value
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
Diluted Earnings per share
0.03
0.08
-0.76
1.38
Operating Profit Margin (Excl OI)
13.82%
11.86%
5.63%
12.46%
Gross Profit Margin
10.3%
7.99%
4.69%
13.39%
PAT Margin
-1.86%
-2.33%
-5.76%
2.98%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 13.85% vs 14.25% in Dec 2023
Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is 25.26% vs 64.73% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 32.64% vs 140.58% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is -4.89% vs 39.32% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of Piramal Pharma With
Figures in Rs cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
6,397.11
9,199.93
-2,802.82
-30.47%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,397.11
9,199.93
-2,802.82
-30.47%
Raw Material Cost
1,852.06
1,471.08
380.98
25.90%
Purchase of Finished goods
870.60
1,244.57
-373.97
-30.05%
(Increase) / Decrease In Stocks
-445.99
-93.01
-352.98
-379.51%
Employee Cost
1,695.46
1,989.92
-294.46
-14.80%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,541.14
2,225.77
-684.63
-30.76%
Total Expenditure (Excl Depreciation)
5,513.27
6,838.33
-1,325.06
-19.38%
Operating Profit (PBDIT) excl Other Income
883.84
2,361.60
-1,477.76
-62.57%
Other Income
92.78
287.35
-194.57
-67.71%
Operating Profit (PBDIT)
976.62
2,648.95
-1,672.33
-63.13%
Interest
317.91
238.94
78.97
33.05%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
658.71
2,410.01
-1,751.30
-72.67%
Depreciation
573.58
405.66
167.92
41.39%
Profit Before Tax
102.18
2,007.79
-1,905.61
-94.91%
Tax
204.21
427.80
-223.59
-52.27%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-119.08
1,576.55
-1,695.63
-107.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-119.08
1,576.55
-1,695.63
-107.55%
Share in Profit of Associates
56.71
9.92
46.79
471.67%
Minority Interest
0.00
-7.70
7.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-62.37
1,570.19
-1,632.56
-103.97%
Equity Capital
1,323.58
40.06
1,283.52
3,203.99%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
10.30%
26.20%
0.00
-15.90%
PAT Margin
-1.86%
17.14%
0.00
-19.00%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 6,397.11 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 13.85% vs 14.25% in Dec 2023
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit -62.37 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 25.26% vs 64.73% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 883.84 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 32.64% vs 140.58% in Dec 2023
Nine Monthly - Interest
Interest 317.91 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -4.89% vs 39.32% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.82%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
